A0A6D2W1K1 (A0A6D2W1K1_PANTR) Pan troglodytes (Chimpanzee)

Cyclin-H UniProtKBInterProInteractive Modelling

323 aa; Sequence (Fasta) ; 3 identical sequences: Homo sapiens: P51946; Pan troglodytes: H2QR75; Gorilla gorilla gorilla: G3QR33

Available Structures

31 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Crystal structure of the dual T-loop phosphorylated Cdk7/CycH/Mat1 complex Heteromer
P50613; P51946; P51948;
1-287
100EDO;
RNA polymerase II pre-initiation complex with the proximal +1 nucleosome (PIC-Nuc10W) Heteromer
A0A287ADR4; A0A4X1TRS6; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VYD0; A0A7M4DUC2; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; P02281; P06897; P13984; P18074; P19447; P20226; P29083; P29084; P32780; P35269; P50613; P51946; P51948; P52655; P52657; P60899; P62799; P84233; Q00403; Q13888; Q13889; Q6ZYL4; Q92759;
2-288
100SF4; 16×ZN;MG;
RNA polymerase II pre-initiation complex with the distal +1 nucleosome (PIC-Nuc18W) Heteromer
A0A287ADR4; A0A4X1TRS6; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VYD0; A0A7M4DUC2; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; P02281; P06897; P13984; P18074; P19447; P20226; P29083; P29084; P32780; P35269; P50613; P51946; P51948; P52655; P52657; P60899; P62799; P84233; Q00403; Q13888; Q13889; Q6ZYL4; Q92759;
2-288
100SF4; 17×ZN;MG;
p53-bound TFIID-based holo PIC on HDM2 promoter Heteromer
A0A481BYI6; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; F1RKE4; I3LCB2; I3LCH3; O00268; P13984; P18074; P19447; P20226; P21675; P24928; P29083; P29084; P32780; P35269; P49848; P50613; P51946; P51948; P52655; P52657; P60899; Q00403; Q12962; Q13888; Q13889; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q6ZYL4; Q7Z7C8; Q92759;
2-288
10016×ZN;SF4;MG;
Cryo-EM structure of CAK in complex with inhibitor ICEC0574 Heteromer
P50613; P51946; P51948;
1-284
100.0X4F;
Structure of the human CDK-activating kinase Heteromer
P50613; P51946; P51948;
1-284
100.0MG;AGS;
Cryo-EM structure of CAK in complex with inhibitor ICEC0880 (ring-up conformation) Heteromer
P50613; P51946; P51948;
1-284
100.0X3Z;
Cryo-EM structure of CAK-THZ1 Heteromer
P50613; P51946; P51948;
1-284
100.0V0G;
Cryo-EM structure of CAK in complex with inhibitor CT7030 Heteromer
P50613; P51946; P51948;
1-284
100.0ZQ6;
Cryo-EM structure of CAK in complex with inhibitor ICEC0880 (ring-down conformation) Heteromer
P50613; P51946; P51948;
1-284
100.0X3Z;
Structure of the human Mediator-bound transcription pre-initiation complex Heteromer
A0JLT2; O15514; O43513; O60244; O75448; O75586; P13984; P18074; P19387; P19388; P19447; P20226; P24928; P29083; P29084; P30876; P32780; P35269; P36954; P50613; P51946; P51948; P52434; P52435; P52655; P52657; P53803; P61218; P62487; P62875; Q00403; Q13503; Q13888; Q13889; Q15528; Q6P2C8; Q6ZYL4; Q71SY5; Q92759; Q96G25; Q96HR3; Q96RN5; Q9BTT4; Q9BUE0; Q9H204; Q9H944; Q9NPJ6; Q9NVC6; Q9NWA0; Q9NX70; Q9P086; Q9ULK4; Q9Y2X0; Q9Y3C7;
1-284
100.0MG; 16×ZN;SF4;
Cryo-EM structure of CAK in complex with inhibitor ICEC0942 Heteromer
P50613; P51946; P51948;
1-284
100.0I74;
Cryo-EM structure of CAK in complex with inhibitor BS-194 Heteromer
P50613; P51946; P51948;
1-284
100.0NS9;
Cryo-EM structure of CAK in complex with nucleotide analogue ATPgS Heteromer
P50613; P51946; P51948;
1-284
100.0AGS;MG;
Cryo-EM structure of CAK in complex with inhibitor ICEC0768 Heteromer
P50613; P51946; P51948;
1-284
100.0X2Z;
Cryo-EM structure of CAK in complex with inhibitor ICEC0829 Heteromer
P50613; P51946; P51948;
1-284
100.0X50;X58;
Cryo-EM structure of CAK in complex with inhibitor BS-181 Heteromer
P50613; P51946; P51948;
1-284
100.0X2H;
Cryo-EM structure of the human CAK bound to ICEC0942 at 2.5 Angstroms resolution Heteromer
P50613; P51946; P51948;
1-284
100.0I74;
Cryo-EM structure of the human CAK bound to ICEC0942 (PHENIX-OPLS3e) Heteromer
P50613; P51946; P51948;
1-284
100.0I74;
TFIID-based holo PIC on SCP promoter Heteromer
A0A481BYI6; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; F1RKE4; I3LCB2; I3LCH3; O00268; P13984; P18074; P19447; P20226; P21675; P24928; P29083; P29084; P32780; P35269; P49848; P50613; P51946; P51948; P52655; P52657; P60899; Q00403; Q12962; Q13888; Q13889; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q6ZYL4; Q7Z7C8; Q92759;
1-284
100.017×ZN;SF4;MG;
Human Mediator with RNA Polymerase II Pre-initiation complex Heteromer
A0A287ADR4; A0A4X1TRS6; A0A4X1VEK9; A0A4X1VYD0; A0A7M4DUC2; A0JLT2; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; O43513; O60244; O75586; P13984; P18074; P19447; P20226; P29083; P29084; P32780; P35269; P50613; P51946; P51948; P52655; P52657; P60899; Q00403; Q13503; Q13888; Q13889; Q15528; Q6P2C8; Q6ZYL4; Q92759; Q96G25; Q96HR3; Q9BTT4; Q9BUE0; Q9H204; Q9H944; Q9NPJ6; Q9NVC6; Q9NWA0; Q9P086; Q9Y3C7;
1-284
100.0SF4; 18×ZN;MG;
Cryo-EM structure of CAK in complex with inhibitor dinaciclib Heteromer
P50613; P51946; P51948;
1-284
100.01QK;
Cryo-EM structure of CAK in complex with inhibitor ICEC0943 Heteromer
P50613; P51946; P51948;
1-284
100.0I73;
Structure of the human CAK in complex with THZ1 Heteromer
P50613; P51946; P51948;
1-284
100.0V0G;
Cryo-EM structure of CAK in complex with inhibitor ICEC0510-S Heteromer
P50613; P51946; P51948;
1-284
100.0X4Q;
Cryo-EM structure of CAK in complex with inhibitor ICEC0510-R Heteromer
P50613; P51946; P51948;
1-284
100.0X4L;
Cryo-EM structure of CAK in complex with inhibitor ICEC0914 Heteromer
P50613; P51946; P51948;
1-284
100.0X1W;
Cryo-EM structure of CAK with averaged inhibitor density Heteromer
P50613; P51946; P51948;
1-284
100.0
Human holo-PIC in the closed state Heteromer
O15514; P13984; P18074; P19387; P19388; P19447; P20226; P23193; P24928; P29083; P29084; P30876; P32780; P35269; P36954; P50613; P51946; P51948; P52434; P52435; P52655; P52657; P53803; P61218; P62487; P62875; Q00403; Q13888; Q13889; Q6ZYL4; Q92759;
11-286
100MG; 17×ZN;SF4;
STRUCTURE OF CYCLIN MCS2homo-2-mer11-287
99.64
CYCLIN H, A POSITIVE REGULATORY SUBUNIT OF CDK ACTIVATING KINASEhomo-2-mer11-286
100

2 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
8orm.1.Bmonomer0.861-284
100.00
7egb.1.Xmonomer0.6461-226
16.67